Medicare Enrolled
Dr. Sasan Sani, M.D.
Pulmonary Disease · Northridge, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sani
Dr. Sasan Sani is a pulmonary disease specialist in Northridge, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Sani performed 4,311 Medicare services across 877 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sani received a total of $10,544 from 30 pharmaceutical and/or device companies across 277 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 6% volume in CA
$10,544 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,311
Medicare services
Top 6% in CA for pulmonary disease
877
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~287 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
1,245 | $63 | $350 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,123 | $100 | $550 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
570 | $33 | $300 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
558 | $177 | $975 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
303 | $89 | $750 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
144 | $147 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
66 | $145 | $700 |
| New patient office visit, complex (60-74 min) | 32 | $169 | $400 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
28 | $91 | $400 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
26 | $12 | $100 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
25 | $35 | $125 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
25 | $50 | $150 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
25 | $40 | $150 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
25 | $52 | $150 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
24 | $69 | $350 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
21 | $150 | $600 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
17 | $115 | $400 |
| Arterial line insertion A tube is inserted into an artery through the skin to allow for blood sampling or infusion. |
16 | $36 | $300 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
14 | $29 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $110 | $275 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
11 | $16 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
0.9% medium
98.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,544
Total received (2018-2024)
Avg $1,506/year across 7 years
Top 15% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
277
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,559 (52.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,985 (47.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,178
2023
$4,624
2022
$839
2021
$662
2020
$534
2019
$315
2018
$392
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$1,585
AstraZeneca Pharmaceuticals LP
$373
GlaxoSmithKline, LLC.
$200
Amgen Inc.
$194
Bayer Healthcare Pharmaceuticals Inc.
$161
United Therapeutics Corporation
$155
Regeneron Healthcare Solutions, Inc.
$142
Pulmonx Corporation
$73
Merck Sharp & Dohme LLC
$67
Actelion Pharmaceuticals US, Inc.
$40
Paratek Pharmaceuticals, Inc.
$36
Insmed, Inc.
$34
Novartis Pharmaceuticals Corporation
$28
Mylan Specialty L.P.
$27
Grifols USA, LLC
$23
Baxter Healthcare
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Top 3 companies account for 67.9% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$3,251
INTUITIVE SURGICAL, INC.
$1,585
AstraZeneca Pharmaceuticals LP
$875
GlaxoSmithKline, LLC.
$723
Actelion Pharmaceuticals US, Inc.
$621
Amgen Inc.
$520
Regeneron Healthcare Solutions, Inc.
$465
Boehringer Ingelheim Pharmaceuticals, Inc.
$444
Bayer HealthCare Pharmaceuticals Inc.
$378
Bayer Healthcare Pharmaceuticals Inc.
$327
United Therapeutics Corporation
$228
Advanced Respiratory, Inc
$152
Philips Electronics North America Corporation
$128
Insmed, Inc.
$112
Pulmonx Corporation
$97
Gilead Sciences, Inc.
$91
Baxter Healthcare
$79
Novartis Pharmaceuticals Corporation
$77
Grifols USA, LLC
$72
Merck Sharp & Dohme LLC
$67
Mylan Specialty L.P.
$51
Paratek Pharmaceuticals, Inc.
$36
Sunovion Pharmaceuticals Inc.
$32
Astellas Pharma US Inc
$26
Electromed, Inc.
$26
AbbVie Inc.
$19
ACADIA Pharmaceuticals Inc
$18
Mallinckrodt Hospital Products Inc.
$16
PORTOLA PHARMACEUTICALS, INC.
$15
ADVANCED RESPIRATORY, INC
$13
Top 3 companies account for 54.2% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BREO · BREZTRI · CHARTIS CATHETER · Cresemba · DUPIXENT · Da Vinci Surgical System · FARXIGA · FASENRA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · ION · LONHALA MAGNAIR · NUCALA · NUPLAZID · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Prolastin-C Liquid · REMODULIN · SHINGRIX · SMARTVEST · STIOLTO RESPIMAT · TERLIVAZ · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · The Volara System · UPTRAVI · UTIBRON NEOHALER · Veklury · Volara System · WINREVAIR · XOLAIR · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
200
Per 100K population
2.0
County median income
$87,760
Nearest hospital
NORTHRIDGE HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sani is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sani experienced with nursing facility visit, low complexity?
Based on Medicare claims data, Dr. Sani performed 1,245 nursing facility visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sani receive payments from pharmaceutical companies?
Yes. Dr. Sani received a total of $10,544 from 30 companies across 277 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sani's costs compare to other pulmonary diseases in Northridge?
Dr. Sani's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Northridge
Browse pulmonary diseases in Northridge ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology